(in millions $) | 30 Oct 2024 | 30 Jul 2024 | 1 May 2024 | 31 Jan 2024 |
---|---|---|---|---|
Current assets | ||||
Cash | ||||
Short term investments | ||||
Net receivables | $5524 | $6070 | $5204 | $4482 |
Inventory | $2393 | $2906 | $2106 | $1944 |
Total current assets | $9407 | $10996 | $9529 | $8298 |
Long term investments | ||||
Property, plant & equipment | $30825 | $30843 | $30839 | $30835 |
Goodwill & intangible assets | ||||
Total noncurrent assets | ||||
Total investments | ||||
Total assets | $42529 | $44135 | $42513 | $41199 |
Current liabilities | ||||
Accounts payable | $6255 | $7563 | $6891 | $5689 |
Deferred revenue | ||||
Short long term debt | ||||
Total current liabilities | $6516 | $7873 | $7106 | $6603 |
Long term debt | $3997 | $4001 | $4006 | $4011 |
Total noncurrent liabilities | ||||
Total debt | ||||
Total liabilities | $18890 | $20199 | $19401 | $18977 |
Shareholders' equity | ||||
Retained earnings | $23305 | $23592 | $22781 | $21907 |
Other shareholder equity | -$635 | -$648 | -$661 | -$677 |
Total shareholder equity |
(in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Jan 2022 | 30 Jan 2021 |
---|---|---|---|---|
Current assets | ||||
Cash | $2153 | $575.55 | ||
Short term investments | ||||
Net receivables | $4719 | $3869 | $1432.53 | |
Inventory | $1514 | $1102 | $866.69 | |
Total current assets | $10736 | $7813 | $3377.17 | |
Long term investments | ||||
Property, plant & equipment | $30751 | $31485 | $23913.38 | |
Goodwill & intangible assets | ||||
Total noncurrent assets | $25012.97 | |||
Total investments | ||||
Total assets | $43524 | $40782 | $28390.14 | |
Current liabilities | ||||
Accounts payable | $5636 | $4667 | $2353.72 | |
Deferred revenue | ||||
Short long term debt | ||||
Total current liabilities | $8898 | $5554 | $2523.17 | |
Long term debt | $4033 | $5054 | $3700.4 | |
Total noncurrent liabilities | $9878.43 | |||
Total debt | ||||
Total liabilities | $21111 | $19047 | $12401.6 | |
Shareholders' equity | ||||
Retained earnings | $21846 | $21660 | $16460.32 | |
Other shareholder equity | -$512 | -$1177 | -$1484.78 | |
Total shareholder equity |
(in millions $) | 30 Oct 2024 | 30 Jul 2024 | 1 May 2024 | 31 Jan 2024 |
---|---|---|---|---|
Revenue | ||||
Total revenue | $13215 | $13348 | $12249 | $13008 |
Cost of revenue | ||||
Gross Profit | $2964 | $2803 | $2879 | $3019 |
Operating activities | ||||
Research & development | ||||
Selling, general & administrative | ||||
Total operating expenses | $1394 | $1335 | $1329 | $1362 |
Operating income | ||||
Income from continuing operations | ||||
EBIT | ||||
Income tax expense | $366 | $356 | $377 | $375 |
Interest expense | $31 | $20 | $20 | $29 |
Net income | ||||
Net income | $1237 | $1133 | $1195 | $1365 |
Income (for common shares) |
(in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Jan 2022 | 30 Jan 2021 |
---|---|---|---|---|
Revenue | ||||
Total revenue | $50702 | $59413 | $37508 | $16712.64 |
Cost of revenue | ||||
Gross Profit | $11424 | $14267 | $8018 | $2647.84 |
Operating activities | ||||
Research & development | ||||
Selling, general & administrative | ||||
Total operating expenses | $5253 | $4980 | $4763 | $4446.21 |
Operating income | -$1797.57 | |||
Income from continuing operations | ||||
EBIT | ||||
Income tax expense | $1480 | $2144 | $804 | -$411.32 |
Interest expense | $125 | $39 | -$21 | |
Net income | ||||
Net income | $4889 | $7340 | $2479 | -$1386.25 |
Income (for common shares) |
(in millions $) | 30 Oct 2024 | 30 Jul 2024 | 1 May 2024 | 31 Jan 2024 |
---|---|---|---|---|
Net income | ||||
Operating activities | ||||
Depreciation | ||||
Business acquisitions & disposals | ||||
Stock-based compensation | ||||
Total cash flows from operations | ||||
Investing activities | ||||
Capital expenditures | ||||
Investments | ||||
Total cash flows from investing | -$1421 | -$937 | -$481 | -$1694 |
Financing activities | ||||
Dividends paid | -$921 | -$599 | -$278 | -$1103 |
Sale and purchase of stock | ||||
Net borrowings | ||||
Total cash flows from financing | -$2145 | -$612 | -$283 | -$4925 |
Effect of exchange rate | ||||
Change in cash and equivalents | $626 | $1156 | $312 | -$2885 |
(in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Jan 2022 | 30 Jan 2021 |
---|---|---|---|---|
Net income | -$1386.25 | |||
Operating activities | ||||
Depreciation | ||||
Business acquisitions & disposals | ||||
Stock-based compensation | ||||
Total cash flows from operations | $595.71 | |||
Investing activities | ||||
Capital expenditures | ||||
Investments | ||||
Total cash flows from investing | -$1694 | -$618 | -$1012 | -$598.69 |
Financing activities | ||||
Dividends paid | -$1103 | -$851 | -$706 | -$484.48 |
Sale and purchase of stock | ||||
Net borrowings | ||||
Total cash flows from financing | -$4925 | -$8268 | -$3082 | -$703.95 |
Effect of exchange rate | ||||
Change in cash and equivalents | -$2885 | $1596 | $1382 | -$706.94 |
Market cap | $34.88B |
---|---|
Enterprise value | N/A |
Shares outstanding | 523.40M |
Revenue | $51.82B |
---|---|
EBITDA | N/A |
EBIT | N/A |
Net Income | $4.93B |
Revenue Q/Q | 101.70% |
Revenue Y/Y | 145.29% |
P/E ratio | 7.07 |
---|---|
EV/Sales | N/A |
EV/EBITDA | N/A |
EV/EBIT | N/A |
P/S ratio | 0.67 |
P/B ratio | N/A |
Book/Share | N/A |
Cash/Share | N/A |
EPS | $9.42 |
---|---|
ROA | 11.57% |
ROE | N/A |
Debt/Equity | N/A |
---|---|
Net debt/EBITDA | N/A |
Current ratio | 1.44 |
Quick ratio | 1.08 |